Sotatercept significantly reduces pulmonary vascular resistance in patients with CpcPH–HFpEF compared with placebo, according to a trial.

Approval for Xeltis’s aXess device was based on pivotal trial data that demonstrated 79% secondary patency and a patency ...

Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a private ...

Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS).

CHI Health Nebraska Heart is hosting a discounted vascular screening event on Saturday, May 9, offering three screenings for ...

Minneapolis-based FLEX Vascular announced the presentation of 12-month results from the FLEX FIRST AV Registry, a prospective ...

Heart health is something many people don’t think about until a problem arises, but experts say daily habits play a major ...

Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 ...

Scientists have made a major advance in developmental neuroscience, creating the very first detailed atlas of how the vascular network of a mouse's brain grows after birth. Their study is published in ...

SSM Health/Saint Louis University School of Medicine Vascular Surgery Integrated Residency (0+5) Program is fully accredited by the Accreditation Council for Graduate Medical Education (ACGME) for one ...

Atherosclerosis involves multiple processes including endothelial dysfunction, inflammation, vascular proliferation and matrix alteration. Vascular proliferation contributes to the pathobiology of ...

Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike ...